Home > Balance Sheet > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹21 Cr₹16 Cr₹22 Cr₹13 Cr₹75 Cr

What is the latest Contingent Liabilities ratio of GLAND PHARMA ?

The latest Contingent Liabilities ratio of GLAND PHARMA is ₹21 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹21 Cr
Mar2024₹16 Cr
Mar2023₹22 Cr
Mar2022₹13 Cr
Mar2021₹75 Cr

How is Contingent Liabilities of GLAND PHARMA Trending?

Years Contingent Liabilities % Change
Mar2025 ₹21 Cr
37.24
Mar2024 ₹16 Cr
-29.41
Mar2023 ₹22 Cr
72.94
Mar2022 ₹13 Cr
-82.91
Mar2021 ₹75 Cr -

Compare Contingent Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,024.2 Cr -1.6% -5.3% 5.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,495.0 Cr -5.7% -3.3% -2.1% Stock Analytics
DIVIS LABORATORIES ₹154,244.0 Cr -3.1% -9.3% 0% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,634.0 Cr -6.1% -8.3% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,594.0 Cr -5.1% -6% 4.8% Stock Analytics
CIPLA ₹97,022.8 Cr -3.3% -11.2% -19.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.6%

-5.3%

5.2%

SENSEX

-1.6%

-8.8%

-4.1%


You may also like the below Video Courses